PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Opioid-Free Mastectomy Anesthesia With Costotransverse Block: Striking Results, Serious Design Caveats

costotransverse blockopioid-free anesthesiaropivacainedexmedetomidinelidocainemagnesium sulfatefentanylbreast cancer surgerymodified radical mastectomymultimodal analgesiaopioid stewardshiprandomized controlled trialQoR-15PONV Pain Management

Background Information

Ultrasound-guided blocks might eliminate opioids in surgery.

This study explores an opioid-free analgesia approach for breast cancer surgery, potentially reducing opioid-related side effects. Group B achieved zero perioperative opioid use with superior pain control and recovery scores compared to Group A. Eliminating opioids in modified radical mastectomy using this method could enhance recovery protocols, though findings are in a specific context. Opioid-free anesthesia using ultrasound-guided costotransverse block with adjuvants may improve outcomes in breast cancer surgery.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Banish TM, Sethi P, Mathur R, Dang D, Kaur M, Kumari K, Sharma N, Bhatia PK

Citation: Banish TM, Sethi P, Mathur R, et al. Ultrasound-guided costotransverse block with systemic adjuvants for complete opioid-free breast cancer surgery: A randomized controlled trial. Journal of anaesthesiology, clinical pharmacology. 2026;42(4):557-564. doi:10.4103/joacp.joacp_746_25

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.